News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biodesix, Inc. Receives Patent for System That Validates Mass Spectrometer Performance



8/19/2013 9:26:29 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the U.S. Patent & Trademark Office has granted the company a patent for a new method and system of validating the performance of matrix-assisted, laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometer machines.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES